Mpagama, Stellah G. http://orcid.org/0000-0002-0660-6930
Mvungi, Happiness C.
Mbelele, Peter M.
Semvua, Hadija H.
Liyoyo, Alphonce A.
de Guex, Kristen Petros
Sloan, Derek
Kibiki, Gibson S.
Boeree, Martin
Phillips, Patrick P. J.
Heysell, Scott K.
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (TMA-SF-1463)
Article History
Received: 18 January 2021
Accepted: 10 March 2023
First Online: 1 April 2023
Declarations
:
: Our proposal has been approved by the Research and Ethics Review Committee (RERC) for three collaborative institutions namely Kibong’oto Infectious Diseases Hospital, Nelson Mandela African Institution of Science and Technology and Center for Educational Development in Health -Arusha acronym KNCHREC. Likewise, the proposal has been approved by the National Health Research Ethics Sub-Committee (NatHREC) of the National Medical Research Institute (NIMR) of Tanzania, and received regulatory approval from the Tanzania Medicines and Diagnostics Agency. Informed consent will be obtained from all study participants. The clinical trial was registered in the PACTR202007736854169 ExternalRef removed. Registered 03 July 2020 and its recruitment began on September 2020.
: Not applicable.
: The authors declare that they have no competing interests.